These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7946455)
1. Acute leukemia and pregnancy--fatal fetal outcome after exposure to idarubicin during the second trimester. Reynoso EE; Huerta F Acta Oncol; 1994; 33(6):709-10. PubMed ID: 7946455 [No Abstract] [Full Text] [Related]
2. Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report. Claahsen HL; Semmekrot BA; van Dongen PW; Mattijssen V Am J Perinatol; 1998 May; 15(5):295-7. PubMed ID: 9643634 [TBL] [Abstract][Full Text] [Related]
3. Idarubicin administered during pregnancy: its effects on the fetus. Matsuo K; Shimoya K; Ueda S; Wada K; Koyama M; Murata Y Gynecol Obstet Invest; 2004; 58(4):186-8. PubMed ID: 15256824 [TBL] [Abstract][Full Text] [Related]
4. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation. Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189 [No Abstract] [Full Text] [Related]
6. [Acute myelogenous leukemia developed at the 26th week of gestation]. Tashiro H; Umezawa K; Shirota M; Oka Y; Shirasaki R; Nishi R; Taguchi A; Akiyama N; Kawasugi K; Ayabe T; Shirafuji N Rinsho Ketsueki; 2011 Jan; 52(1):18-22. PubMed ID: 21378477 [TBL] [Abstract][Full Text] [Related]
7. Fetal death following idarubicin treatment for acute promyelocytic leukemia in pregnancy-A case report. Maruyama S; Sato Y; Moriuchi K; Kanbayashi S; Ri Y; Taga A; Emoto I; Kim T Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():140. PubMed ID: 28987888 [No Abstract] [Full Text] [Related]
8. Persistent hiccups as an adverse event to FLAG-IDA regimen for leukemia. Forghieri F; Maccaferri M; Morselli M; Potenza L; Volzone F; Bandieri E; Torelli G; Luppi M Acta Oncol; 2009; 48(6):932-3. PubMed ID: 19235569 [No Abstract] [Full Text] [Related]
9. Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Niedermeier DM; Frei-Lahr DA; Hall PD Pharmacotherapy; 2005 Aug; 25(8):1134-40. PubMed ID: 16207105 [TBL] [Abstract][Full Text] [Related]
10. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia]. Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381 [TBL] [Abstract][Full Text] [Related]
11. [Acute lymphoblastic leukemia with breast infiltration during the second trimester of pregnancy and followed by successful delivery]. Bohgaki T; Notoya A; Mukai M; Kohno M Rinsho Ketsueki; 1999 Aug; 40(8):652-7. PubMed ID: 10496040 [TBL] [Abstract][Full Text] [Related]
12. Multi-agent chemotherapy in a case of non-Hodgkin's lymphoma in second trimester of pregnancy. Moore DT; Taslimi MM J Tenn Med Assoc; 1991 Sep; 84(9):435-6. PubMed ID: 1921384 [No Abstract] [Full Text] [Related]
13. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience. Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308 [No Abstract] [Full Text] [Related]
14. Stage III melanoma treated with chemotherapy after surgery during the second trimester of pregnancy. Ishida I; Yamaguchi Y; Tanemura A; Hosokawa K; Itami S; Morita A; Katayama I Arch Dermatol; 2009 Mar; 145(3):346-8. PubMed ID: 19289786 [No Abstract] [Full Text] [Related]
15. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Chelghoum Y; Vey N; Raffoux E; Huguet F; Pigneux A; Witz B; Pautas C; de Botton S; Guyotat D; Lioure B; Fegueux N; Garban F; Saad H; Thomas X Cancer; 2005 Jul; 104(1):110-7. PubMed ID: 15912518 [TBL] [Abstract][Full Text] [Related]
16. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia. Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970 [TBL] [Abstract][Full Text] [Related]
17. Rituximab combined with chemotherapy for lymphoma during pregnancy. Rey J; Coso D; Roger V; Bouayed N; Belmecheri N; Ivanov V; Gastaut JA; Bouabdallah R Leuk Res; 2009 Mar; 33(3):e8-9. PubMed ID: 18490055 [No Abstract] [Full Text] [Related]
20. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study. Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]